Please check your internet connection and try again.
# Diclofenac
## Overview
Diclofenac is a nonsteroidal anti-inflammatory drug (NSAID) used to treat pain and inflammation.
## Primary Indications
* Pain associated with osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis.
* Mild to moderate pain.
* Acute gouty arthritis.
## Adult Dosing
* **Osteoarthritis, Rheumatoid Arthritis, Ankylosing Spondylitis:** 150-200 mg per day in divided doses (e.g., 50 mg TID or 75 mg BID). Maximum daily dose is 200 mg.
* **Mild to Moderate Pain:** 25 mg every 6-8 hours as needed. Do not exceed 75 mg in 24 hours.
* **Acute Gouty Arthritis:** 50 mg TID for 3 days.
## Pediatric Dosing
* **Rheumatoid Arthritis:** 2-3 mg/kg per day in divided doses. Maximum daily dose is 200 mg. Dosing for children under 1 year is not established.
## Dose Adjustments
* **Hepatic Impairment:** Use with caution; consider lower doses.
* **Renal Impairment:** Use with caution; monitor renal function. Data for severe renal impairment is limited.
## Contraindications
* Hypersensitivity to diclofenac, aspirin, or other NSAIDs.
* History of asthma, urticaria, or allergic-type reactions after taking aspirin or other NSAIDs.
* Perioperative pain in the setting of coronary artery bypass graft (CABG) surgery.
## Adverse Effects
* **Common:** Gastrointestinal upset (nausea, vomiting, diarrhea, constipation, abdominal pain), dizziness, headache.
* **Serious:**
* **Cardiovascular:** Increased risk of myocardial infarction, stroke, and heart failure.
* **Gastrointestinal:** Ulceration, bleeding, perforation.
* **Hepatic:** Elevated liver enzymes, hepatitis.
* **Renal:** Renal impairment, interstitial nephritis.
* **Dermatologic:** Serious skin reactions (e.g., Stevens-Johnson syndrome, toxic epidermal necrolysis).
* **Hypersensitivity:** Anaphylaxis.
## Key Drug Interactions
* **ACE Inhibitors, ARBs, Beta-blockers:** Reduced antihypertensive effect; increased risk of renal impairment.
* **Corticosteroids:** Increased risk of GI ulceration and bleeding.
* **Diuretics:** Reduced diuretic and antihypertensive effect; increased risk of renal impairment.
* **Lithium, Methotrexate:** Increased serum concentrations and toxicity.
* **Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs):** Increased risk of GI bleeding.
* **Warfarin:** Increased risk of bleeding.
## Monitoring
* **Baseline and periodic:** Liver function tests (LFTs), renal function tests (BUN, creatinine), complete blood count (CBC).
* Monitor for signs and symptoms of GI bleeding, cardiovascular events, and hypersensitivity reactions.
## Clinical Pearls
* Use the lowest effective dose for the shortest duration necessary to minimize risks.
* Consider gastroprotective agents (e.g., PPIs) in patients at high risk for GI bleeding.
* NSAIDs can mask signs of infection.
* Avoid concurrent use with other NSAIDs.
***
*Please verify current prescribing information for the most up-to-date details on dosing, contraindications, and interactions.*